These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 782898)

  • 1. Quantum pharmacology and quantitative structure-activity relationships: a brief review.
    Joyner JC; Purcell WP
    Experientia Suppl; 1976; 23():13-23. PubMed ID: 782898
    [No Abstract]   [Full Text] [Related]  

  • 2. Structural chemistry of cholinergic neural transmission systems. II. A quantum theoretical study of the molecular electronic structure of muscarine, nicotine, acetyl- -methylcholine, acetyl- -methylcholine, acetyl- , -dimethylcholine, and further studies on acetylcholine.
    Radna RJ; Beveridge DL; Bender AL
    J Am Chem Soc; 1973 Jun; 95(12):3831-46. PubMed ID: 4710055
    [No Abstract]   [Full Text] [Related]  

  • 3. Calculations of Henry constants and partition coefficients using quantum chemical approach.
    Zahradník R; Hobza P; Slanina Z
    Experientia Suppl; 1976; 23():217-30. PubMed ID: 954937
    [No Abstract]   [Full Text] [Related]  

  • 4. Electrostatic stabilization of cholinergic substrates.
    Ajó D; Bossa M; Damiani A; Fidenzi R; Gigli S; Lanzi L; Lapiccirella A
    J Theor Biol; 1972 Jan; 34(1):15-20. PubMed ID: 5017021
    [No Abstract]   [Full Text] [Related]  

  • 5. Commentary: The receptor concept in evolution.
    Ariëns EJ; Beld AJ
    Biochem Pharmacol; 1977 May; 26(10):913-8. PubMed ID: 324474
    [No Abstract]   [Full Text] [Related]  

  • 6. Quantum chemistry in drug research.
    Richards WG; Black ME
    Prog Med Chem; 1975; 11():67-90. PubMed ID: 1129504
    [No Abstract]   [Full Text] [Related]  

  • 7. [Structure- and conformation-activity relationships of heterocyclic acetylcholine analogues. 16. Conformational behaviour and cholinergic properties of isoarecaidine and sulfoisoarecaidine esters].
    Höltje HD; Lambrecht G; Moser U; Mutschler E
    Arzneimittelforschung; 1983; 33(2):190-7. PubMed ID: 6601954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinaton of thermodynamics of functional groups in solutions of drug molecules.
    Davis SS
    Adv Pharm Sci; 1974; 4():73-261. PubMed ID: 4618036
    [No Abstract]   [Full Text] [Related]  

  • 9. Assessment of quantum mechanical techniques for use in structure activity relationship development, and application to analgesics and other drugs.
    Cheney BV; Duchamp DJ; Christoffersen RE
    NIDA Res Monogr; 1978; (22):218-49. PubMed ID: 30908
    [No Abstract]   [Full Text] [Related]  

  • 10. [Structure- and conformation-activity relationships of heterocyclic acetylcholine analogs. 17. Conformational behavior and cholinergic properties of arecaidine and sulfoarecaidine esters].
    Mutschler E; Höltje HD; Lambrecht G; Moser U
    Arzneimittelforschung; 1983; 33(6):806-12. PubMed ID: 6684432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of drug-enzyme interactions.
    Handschumacher RE; Hare LE
    Anesthesiology; 1973 Aug; 39(2):165-77. PubMed ID: 4198288
    [No Abstract]   [Full Text] [Related]  

  • 12. [Quantum pharmacology: state of scientific research].
    Chekman IS
    Lik Sprava; 2007; (8):3-11. PubMed ID: 18714459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Structure- and conformation-activity relationship of heterocyclic acetylcholine analogs. 13. Cholinergic properties of tertiary and quaternary 4-acetoxyquinuclidines].
    Lambrecht G
    Arzneimittelforschung; 1982; 32(2):130-4. PubMed ID: 7199915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantum chemical studies on molecular determinants for drug action.
    Weinstein H; Osman R; Topiol S; Green JP
    Ann N Y Acad Sci; 1981; 367():434-51. PubMed ID: 6942761
    [No Abstract]   [Full Text] [Related]  

  • 15. [Structure-activity relationships of cyclic analogs of acetylcholine].
    Lambrecht G
    Pharmazie; 1976 Apr; 31(4):209-15. PubMed ID: 935221
    [No Abstract]   [Full Text] [Related]  

  • 16. Ranking poses in structure-based lead discovery and optimization: current trends in scoring function development.
    Rajamani R; Good AC
    Curr Opin Drug Discov Devel; 2007 May; 10(3):308-15. PubMed ID: 17554857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A practitioner's perspective of the role of quantitative structure-activity analysis in medicinal chemistry.
    Martin YC
    J Med Chem; 1981 Mar; 24(3):229-37. PubMed ID: 7265109
    [No Abstract]   [Full Text] [Related]  

  • 18. Implications of a circular dichroism and theoretical investigation of ribavirin-related derivatives in drug design.
    Miles DL; Miles DW; Eyring H
    Ann N Y Acad Sci; 1981; 367():518-30. PubMed ID: 6114699
    [No Abstract]   [Full Text] [Related]  

  • 19. Classification of drugs by discriminant analysis using fragment molecular connectivity values.
    Henry DR; Block JH
    J Med Chem; 1979 May; 22(5):465-72. PubMed ID: 458797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular orbital calculations for the structure of the muscarine-pharmacophore].
    Höltje HD
    Arch Pharm (Weinheim); 1974 Dec; 307(12):969-72. PubMed ID: 4451455
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.